Research Indicates Improving Lymphatic Function Protects Mice from Experimental Colitis

by Kathy Jones on  August 9, 2014 at 11:09 PM Research News
RSS Email Print This Page Comment
Font : A-A+

It is widely known that chronic inflammatory bowel disease can be painful and debilitating.

Both genetics and environment are thought to promote disease, but it is not fully understood how chronic IBD develops.
 Research Indicates Improving Lymphatic Function Protects Mice from Experimental Colitis
Research Indicates Improving Lymphatic Function Protects Mice from Experimental Colitis

Emerging evidence indicates that IBD is associated with an increase in lymphatic vasculature, which transports lymph throughput the body. It is not clear if these lymphatic vessels promote or improve IBD. A new study in the Journal of Clinical Investigation indicates that improving lymphatic function relieves experimental IBD in mice. Silvio Danese and colleagues at Humanitas Clinical and Research Center gave mice a compound called VEGF-C that improves lymphatic function prior to the onset of experimental IBD. VEGF-C treatment prevented development of both chronic and acute IBD. This study indicates that augmenting lymphatic function helps prevent intestinal inflammation and suggests that VEGF-C should be further tested for use in IBD.


Source: Eurekalert

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Modified Atkins Diet: All You Need to Know 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive